SPAG11B (61-103) (Human) [7403]
SPAG11B (61-103) (Human)
| SMILES |
CCC(C)C(NC(=O)C(Cc1c[nH]cn1)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(Cc1ccc(O)cc1)NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(NC(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C1CCCN1C(=O)C(CC(C)C)NC(=O)C(CC(C)C)NC(=O)C(N)CC(=O)O)C(C)O)C(C)C)C(=O)NC(CO)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC(=O)O)C(=O)NC(C)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)N1CCCC1C(=O)NC(CO)C(=O)NC(Cc1ccccc1)C(=O)NC(CCCN=C(N)N)C(=O)NC(C(=O)NC1CSSCC(C(=O)NC(CO)C(=O)NC(C(=O)NCC(=O)NC(CC(N)=O)C(=O)O)C(C)O)NC(=O)CNC(=O)C(CCCN=C(N)N)NC(=O)C(C)NC(=O)C(Cc2c[nH]c3ccccc23)NC(=O)C(CCCN=C(N)N)NC(=O)C2CCCN2C(=O)CNC(=O)C(CC(C)C)NC(=O)C(Cc2ccccc2)NC(=O)C(CC(=O)O)NC(=O)C(C(C)C)NC1=O)C(C)CC |
| InChIKey |
NZRXPCZWIFPFBB-UHFFFAOYSA-N |
| Sequence |
DLLPPRTPPYQVHISHREARGPSFRICVDFLGPRWARGCSTGN |
| HELM |
PEPTIDE1{D.L.L.P.P.R.T.P.P.Y.Q.V.H.I.S.H.R.E.A.R.G.P.S.F.R.I.C.V.D.F.L.G.P.R.W.A.R.G.C.S.T.G.N}$PEPTIDE1,PEPTIDE1,27:R3-39:R3$$$ |
Chemical Properties
| Hydrogen bond acceptors |
None |
| Hydrogen bond donors |
None |
| Rotatable bonds |
None |
| Log P |
None |
| Molecular weight (Da) |
None |
No bioactivity data available.
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.